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Initial elimination of invading Staphylococcus aureus from the body is mediated by profes-
sional phagocytes.The neutrophil is the major phagocyte of the innate immunity and plays
a key role in the host defense against staphylococcal infections. Opsonization of the bac-
teria with immunoglobulins and complement factors enables efficient recognition by the
neutrophil that subsequently leads to intracellular compartmentalization and killing. Here,
we provide a review of the key processes evolved in neutrophil-mediated phagocytosis of
S. aureus and briefly describe killing. As S. aureus is not helpless against the professional
phagocytes, we will also highlight its immune evasion arsenal related to phagocytosis.
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INTRODUCTION
Staphylococcus aureus is a human commensal but also a common
course of serious infections, ranging from mild skin infections
to more serious life-threating wound and bloodstream infections
(1). The innate immunity is an important part of the host defense
in elimination of infections caused by S. aureus. Notably, many
virulence factors of S. aureus are directed toward elements of
the innate immune defense including its principal phagocyte, the
neutrophil (2–4).
In the human blood, neutrophils are the predominant phago-
cytic cell type, accounting for 50–60% of all leukocytes. The
acknowledgment for professional phagocytes started with the first
description of motile cells capable of engulfing other matter by
Ilya Ilyich Mechnikov, a Russian biologist, best known for his pio-
neering research on the immune system. Mechnikov received the
Nobel Prize in Medicine, jointly with Paul Ehrlich, in 1908 for
his work on phagocytosis, which is defined as the uptake of bac-
teria, parasites, dead host cells, and foreign debris. In addition
to neutrophils, dendritic cells, monocytes, and macrophages are
considered professional phagocytes, and all cell types are critical
in controlling bacterial infection, all be it through different means.
Neutrophils are ready-to-go cells, show a fast response, and
have a generally believed short half-life of <7 h. Recent in vivo
labeling studies, however, estimated the lifespan of neutrophils
to be much longer, i.e., 5.4 days (5). Neutrophils are rapidly
mobilized from the bone marrow into the circulation, and sev-
eral subtypes are now characterized based on differential surface
antigen expression and function in innate immunity (6–8). The
last decade, the role of neutrophils in several other aspects of
immunity is appreciated as it has become clear that neutrophils
also participate in processes associated with the adaptive immu-
nity and tumor immunology. They display cross talk with adap-
tive immune cells, i.e., dendritic cells, lymphocytes, and natural
killer cells, through secretion of cytokines and reactive oxygen
species (ROS), and they interact directly with cells of adaptive
immunity via cell surface molecules (9), functions that are most
likely associated with different subpopulations or activation states
(10, 11). As neutrophils are circulating cells, they first need to
leave the bloodstream via diapedesis to reach the site of infec-
tion through directed migration along an increasing gradient
of chemoattractants, which are derived from bacteria, generated
via complement activation or secreted by activated cells includ-
ing leukocytes (12). For efficient phagocytosis, bacteria need to
be covered with opsonins provided by specific immunoglobu-
lins (Igs), the complement system, and others. Uptake of bacteria
leads to full activation of the anti-microbial arsenal of the neu-
trophil leading to killing of the ingested bacteria. The neutrophil is
equipped with two major pathways for killing, generation of ROS,
and degranulation of granules packed with proteases and specific
anti-microbial peptides. The active phagocytosis by neutrophils is
eventually followed by a more passive form of elimination of the
micro-organisms as the lifetime of the cell is consumed through
the formation of neutrophil extracellular traps (NETs) that con-
sist of chromatin and granule content (13). It should be noted
that neutrophils and its arsenal of anti-microbials employed to
fight infection, sometimes turn against the host itself causing
inflammation (14).
OPSONIZATION AND RECOGNITION OF S. AUREUS
For neutrophils, initiation of phagocytosis requires decoration of
bacteria with opsonins that are recognized by specific surface
receptors. Igs and complement components are the predomi-
nant factor in serum that enables efficient opsonization. They
are deposited on the surface of the bacterium and enable recog-
nition by Fc receptors (FcRs) and complement receptors (CRs),
respectively, which trigger the phagocytic machinery (Figure 1).
Therefore, the interface between the specific opsonins and their
receptors dictates phagocytosis and is influenced by both the target
(bacterium) and effector (neutrophil) characteristics. Indirectly,
the availability and nature of the opsonins are major determi-
nants in the process but are dependent on the target bacterium,
and the generation of specific Igs is part of the adaptive immune
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FIGURE 1 | Interface neutrophil and S. aureus. Several groups of receptors
mediate neutrophils recognition of S. aureus upon opsonization and others
are involved in activation or priming of phagocytosis. Targets on the S. aureus
surface are the cell wall components peptidoglycan (PG), wall teichoic acid
(WTA), lipoteichoic acid (LTA), capsule (“gray area”), and representative
associated proteins clumping factor A (ClfA) and protein-A (Spa). Targets are
decorated with serum derived opsonins IgG (binding with their Fab part) and
C3b. Note the reverse Fc-dependent association of IgG with Spa. Receptors
on the neutrophil surface involved in recognition of the opsonized S. aureus
are FcγRII and FcγRIII for IgG, and CR1 and CR3 for C3b (and iC3b). Examples
of receptors on the neutrophil involved in priming or activation of
phagocytosis are complement receptors C3aR for C3a and C5aR for C5a,
CXCR1 for il-8, and TNFR for TNFα. The heterodimer TLR2/TLR6 represents a
common pattern recognition receptor for bacterial lipoproteins.
response and depends on antigen presentation, memory, and
affinity maturation.
The most logical target candidates are of course surface-
exposed proteins and general cell wall components, like peptido-
glycan and wall teichoic acid (WTA) (15, 16). Since most humans
are exposed to staphylococci already early in life without causing
serious diseases, common structures, and/or proteins present on
most staphylococci generate adequate Ig levels in normal healthy
people. These structures provide sufficient natural occurring IgG
that mediate recognition through FcγRs and also initiate clas-
sical pathway complement activation and thereby increase the
amount of surface-bound opsonins, enabling uptake by neu-
trophils. Although the individual IgG levels by themselves do
not seem to be that high, the power of the host defense is the
combination of multiple IgG against several target molecules with
complement activation. Lectin and alternative pathway-mediated
complement activation results in the deposition of C3b/C3bi
on the bacterial surface that is recognized by neutrophil CRs.
Although phagocytosis is initiated, this system seems not to be
so efficient in promotion of uptake of bacteria. On the other side
of the spectrum, antibodies alone, and more specifically IgG, do
trigger the FcγRs on the neutrophil to ingest the bacteria. For
opsonization, location of the bound antibodies in relation to com-
plement deposition and presentation to the neutrophil FcRs and
CRs influences the opsonophagocytic potential. Thus, the efficacy
of phagocytosis depends on the presence of specific IgG that acti-
vates the complement system via classical pathway resulting in
C3b/C3bi deposition and binding to the FcγRs. The combina-
tion of these two key opsonins, complement, and IgG, triggers the
phagocytic machinery into a high speed mode (17).
The attributed role of opsonins in neutrophil-mediated phago-
cytosis may, however, be dependent on the methodology, related to
the site of infection. A recent example (18) showed that phagocy-
tosis of S. aureus by human neutrophils in suspension depends
on opsonization, while adherent neutrophils internalize more
bacteria independent of opsonization. Consequently, addition of
specific IgG did not enhance uptake by adherent neutrophils
but improved the process in suspension. Remarkably, killing of
the bacteria was only evident with adherent neutrophils when
serum-induced aggregation phenomena were excluded. Under
suspension conditions, persistence of free extracellular bacteria
contributed substantially to the poor killing.
IMMUNOGLOBULINS AND THEIR RECEPTORS IN
RECOGNITION OF S. AUREUS
Immunoglobulin is the second most abundant protein in
serum/plasma after albumin and provides life-long protection
against infectious agents. Igs are important for proper opsoniza-
tion of bacteria and subsequent recognition by specific FcR on the
surface of phagocytes. Several Ig subtypes exist and they display
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specific functions; while IgG (IgG1, IgG2, IgG3, and IgG4), IgM
and secretory IgA of the mucosal tissues have roles in infec-
tion control, IgE does not. Different IgG subclasses bind differ-
ent FcγRs. Normal peripheral blood neutrophils express FcγRII
(CD32) and FcγRIIIB (CD16), and do not express the FcγR1
(CD64) that is found on monocytes. However, during systemic
infections and sepsis neutrophils do express FcγRI. Together with
other activation-related surface antigens, expression of CD64 is
used as specific sign of bacterial infections and marks the activa-
tion status of the neutrophil (19, 20). Most phagocytes including
neutrophils express specific receptor for IgA (FcαR or CD89).
When appropriate specific IgA antibodies are present, the FcαR
initiated responses are comparable with those of IgG and FcγRII.
In contrast to IgG, IgA does not activate the complement system.
The binding characteristics between different Ig classes and the
various FcRs are well documented; please refer to some excellent
reviews (21–23).
For proper Ig opsonization, generation of target-specific Igs is
crucial. In the case of S. aureus, effective Igs are directed against
its surface molecules. The outer surface of Gram-positive bacte-
ria, including S. aureus, contains a thick layer of peptidoglycan
that is decorated with covalently anchored proteins that can initi-
ate both IgG and complement deposition. The cell wall-associated
proteins are often virulence factors and have been shown to influ-
ence pathogenesis (24). Naturally occurring antibodies directed
against these proteins, like clumping factor A (ClfA) and protein-
A, circulate in human serum, and several of these proteins are used
as vaccine candidates to elicit protective antibodies. The presence
of specific naturally occurring IgG directed against several surface-
exposed cell wall components and proteins of S. aureus has been
described by several studies that demonstrate that IgG provides the
host with a handle to recognize and phagocytose the bacterium.
Much research has been performed on the efficacy of antibodies
directed against specific staphylococcal targets. However, several
studies also document a larger approach. Using a bead-based
Luminex screening against 56 staphylococcal antigens – includ-
ing many known virulence factors, surface-exposed, and secreted
proteins, but also peptidoglycan and WTA – IgG and IgA levels in
multiple serum samples of patients with a S. aureus bacteremia and
non-infected controls were compared (25). IgG directed against
all antigens were detected in healthy controls as well as patients
at the time of diagnosis. In the majority of bacteremia patients,
the IgG levels showed a temporal increase. Using classical ELISAs
on 19 staphylococcal cell surface and secreted proteins, a wide
range of antibody levels in both healthy donors and patients
was observed (26). Here, the majority of IgG was induced by
lipoteichoic acid (LTA) and peptidoglycan. The amount of anti-
staphylococcal antibodies accounted for 0.1–3% of total serum
antibodies and was already obvious in healthy adolescents aged
13–15 years. The total anti-staphylococcal IgG levels correlated
with a functionality opsonophagocytosis assay using fluorescently
labeled bacteria and P388.D1 mouse macrophage cells. A compa-
rable ELISA screening study (27) was performed against 11 dif-
ferent purified antigens from S. aureus, including surface antigens
(such as teichoic acid and clumping factors A and B) and secreted
proteins (such as alpha-toxin, lipase, enterotoxin A, toxic shock
syndrome toxin, scalded-skin syndrome toxin, fibrinogen-binding
protein, and extracellular adherence protein). Most healthy indi-
viduals (15–89 years) had circulating IgG antibodies against these
antigens, whereby titers against teichoic acid were the highest. An
alternative strategy to demonstrate the antibody repertoire used 2-
D immunoblots with sera from patients with S. aureus bacteremia
on the extracellular protein profile of the infecting S. aureus strain
(28). Pre-existing antibodies were present and the pattern of anti-
body response was distinct for carriers and non-carriers, but also
did contain a common signature.
In addition to the wide studies pertaining to groups of S.
aureus surface epitopes, much research has been done on spe-
cific staphylococcal antigens, i.e., peptidogylcan, the cell WTA (a
glycopolymer covalently linked to peptidoglycan), polymeric-N -
acetylglucosamine (PNAG) (29, 30), N -acetylglucosamine (Glc-
Nac) (31), iron-regulated surface protein B (IsdB) (32, 33), and
ClfA (34, 35). As an example, interesting studies have been pub-
lished on the opsonizing capacity of peptidoglycan. Elevated IgG
levels to peptidoglycan were observed in patients with deep tis-
sue infection with S. aureus but hardly in patients with superficial
staphylococcal infection (36). Peptidoglycan appeared to be the
key cell wall component involved in staphylococcal opsonization,
both by IgG and activating complement (37). By itself, peptido-
glycan and its soluble parts are also potent activators of the host
defense leading to pro-inflammatory cytokine release from mono-
cytes (38) and oxidative burst in neutrophils (39), only valid for
the polymeric form of peptidoglycan. In addition, small dipep-
tides or tripeptides derived from polymeric peptidoglycan trigger
cytoplasmic nucleotide oligomerization domain (NOD) receptors
leading to NF-kB activation (40). For Bacillus anthracis-derived
peptidoglycan it has been shown that specific IgG mediates bac-
terial binding to monocytes and neutrophils. All tested healthy
donors contained IgG recognizing peptidoglycan. The authors
suggest that IgG facilitates uptake of complex peptidoglycan,
where after small derivatives trigger NODs for cytokine release
(41). Alternatively, the pentraxin serum amyloid P binds to pep-
tidoglycan on the surface of S. aureus (in the absence of WTA
in a dTagO strain) and subsequently to FcγR, which induces
complement and IgG-independent phagocytosis (42). Notably,
another pentraxin, C-reactive protein, was ineffective under iden-
tical conditions, and the presence of WTA seems to prevent this
process. Pentraxins are known to bind and activate FcγRs in a
structural similar fashion as IgGs do (43). In addition to Igs and
pentraxins, mannose binding lectin (MBL) also recognizes pep-
tidoglycan resulting in cytokine release from macrophages (44).
WTA is also recognized by MBL and functions as an opsonins
but only when anti-WTA IgG are not yet present like in infants
(45). On the other hand, affinity purified anti-WGA IgG induces
classical complement-mediated opsonophagocytosis of S. aureus
(46). Using glycosyltransferase KO/mutant strains, beta-GlcNAc
residues of WTA are shown to be required for the induction of
the classical complement pathway-dependent opsonophagocyto-
sis of S. aureus. MBL recognized both α- and β-GlcNAc residues
of WTA. In normal human serum, the major antibodies to WTA
are specific to β-GlcNAc-modified form (47).
Next to IgG, natural occurring IgM antibodies activate com-
plement and thereby also have opsonophagocytic capacity. IgM
against S. aureus is present in human serum as was demonstrated
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by a study using a multiplex Luminex assay 34. The level of
S. aureus-specific IgM was relatively low, and IgM was directed
mostly to microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs). When healthy donors and
patients with infections were examined by ELISA, IgM antibodies
to peptidoglycan were not detected (36). Dimeric IgA linked via the
J chain and monomeric IgA found in serum are good opsonins for
bacteria and promote neutrophil oxidative burst and phagocytosis
as efficient as IgG (48).
Because IgG is of the highest importance for S. aureus opsoniza-
tion, many studies focus on the identification of likely anti-
gens for possible therapy. Some studies have used intravenous
immunoglobulin (IVIgG) as a source to identify new IgG targets.
IVIgG is a pool of IgG isolated from hundreds of healthy blood
donors that is commonly used as replacement therapy in immuno-
compromised patients. The broad antibody spectrum present in
such a pool provides protection against otherwise life-threatening
infections and autoimmune diseases (49). Subtractive proteome
analysis of S. aureus anchorless cell wall proteins was performed
by screening for proteins reacting with IVIgG but not with IVIgG
depleted of S. aureus-specific opsonizing antibodies. Three of the
40 candidate proteins, i.e., enolase, oxoacyl reductase, and hypo-
thetical protein hp2160, were used as vaccine candidates in mice
and provided protection. Affinity isolation of the IgGs from IVIgG
resulted in opsonization, phagocytosis, and killing of S. aureus by
human neutrophils (50). In addition, on studies using IVIgG, oth-
ers have applied bioinformatics for antigen prediction selecting for
lipoproteins and cell wall-anchored proteins from Streptococcus
sanguinis. Eight protein candidates were randomly picked, pooled,
and used to immunize rabbits. From the raised antibody pool,
affinity chromatography demonstrated opsonic activity for the
individual IgGs with human neutrophils and rabbit complement
(51). Using DNA bar-coding and deep sequencing of IgG genes
from S. aureus infected humans identified protective antibodies
that promoted opsonophagocytosis (52).
COMPLEMENT ACTIVATION AND RECOGNITION DURING S.
AUREUS INFECTION
The complement system is part of the innate immune defense
and is a complex regulated system of proteases leading to soluble
and surface-bound factors that contribute to efficient phagocy-
tosis (53). Complement activation proceeds via three pathways,
all leading to the cleavage of C3 into surface-deposited C3b (that
also gets fragmented to iC3b) and released soluble mediator C3a.
The “classical” activation of complement is mediated by specific
antibodies bound to the bacterial surface that activate C1. Bacteri-
ally exposed carbohydrates are recognized by host lectins, mainly
MBL, initiating the “lectin pathway.” Spontaneous and/or surface
antigen-specific activation of C3 is possible as well as an ampli-
fication of the already-deposited C3b through the “alternative
pathway.” The surface-bound C3b convertases activate new C3
molecules leading to more deposition of C3b onto the bacterial
surface. The binding of C5 to the surface-bound C3b convertases
subsequently initiates the release of the soluble mediator C5a and
the formation of the membrane attack complex composed of C5b,
C6, C7, C8, and multiple C9 molecules. The pores formed by the
membrane attack complex may directly induce lysis of susceptible
of mainly Gram-negative bacteria. The soluble cleavage products
C3a and C5a, also known as anaphylatoxins (54), are chemoat-
tractants and activators for phagocytes that express the C3aR and
C5aR. With respect to phagocytosis, the bacterial surface-bound
C3b is a key opsonin and is recognized by CRs on neutrophils.
Both the complement factors as their receptors play several roles in
phagocytosis. As the classical pathway is dependent on IgG, which
was discussed in the previous section,more emphasis will be placed
on other complement opsonin strategies in this section. Important
group of CRs on neutrophils are lectins, those for bacterial surface-
bound C3b or iC3b that belong to the adhesion receptor family
and those for the soluble anaphylatoxins C3a and C5a that are G
protein-coupled receptors (GPCRs).
Receptors that recognize surface-deposited complement factors
are CR1 (CD35), CR2 (CD21), CR3 (CD11b/CD18 or MAC-1),
CR4 (CD11c/CD18, integrin αXβ2), and CR of the Ig super-
family, CRIg (55). They all recognize C3b and/or iC3b, through
distinct binding sites. Neutrophils express CR1 and CR3, whereas,
macrophages express CR3 and CR4. CRIg is found on monocyte-
derived macrophages and liver Kupfer cells (56). CR1 is a mem-
brane glycoprotein with specificity for the complement products
C3b, C4b and, with lower affinity, iC3b. It shares structural simi-
larities with several regulators of complement activation, and the
extracellular domain of CR1 consists of an array of 30 or more
homologous units (57, 58). CR3 and CR4 are heterodimeric gly-
coproteins with a shared β-chain (CD18). Both receptors show
specificity for the iC3b fragment (59, 60). Finally, CRIg is shown to
mediate efficient phagocytosis of complement-opsonized particles
and participates in the initial stage of phagosome formation (56).
Three cell-associated proteins have been described that show
affinity for complement factor C1q, which is deposited upon
recognition of surface-bound IgM. cC1qR, which closely resem-
bles calreticulin, binds the collagen-like tail of C1q. C1qRp is a
phagocytosis-promoting receptor that has similar ligand speci-
ficity, and gC1qR recognizes the globular head regions of C1q.
Receptors for C1q are thought to play a role in both triggering and
regulation of complement activation, and neutrophils express all
three types of receptors (55, 61).
Pertaining to complement and specific recognition of S. aureus,
although all three complement pathways play a role, lectins have
thoroughly been investigated. Direct binding of MBL to sev-
eral micro-organisms, including S. aureus, was demonstrated by
flow cytometry, and bound MBL promoted deposition of C4
(62). The contribution of the MBL–MASP pathway relative to
other pathways of complement activation on S. aureus and the
consequence for C3b deposition and phagocytosis was demon-
strated using MBL-deficient sera (63). MBL–MASP added to
deficient sera enhanced the generation of C3b and iC3b on the
surface of staphylococci and subsequently increased phagocyto-
sis by human neutrophils. It must be noted that others have
observed that while yeast species are preferentially opsonized
and subsequently phagocytosed via activation of the lectin path-
way of complement, the uptake of bacterial strains, includ-
ing S. aureus, was largely MBL independent (64). Using MBL-
deficient sera, it was shown that there was less C3 deposition
on zymosan and Candida, while C3 deposition was not differ-
ent on S. aureus using MBL-sufficient and MBL-deficient serum.
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Same authors have shown that inhibition of the classical path-
way of complement activation during opsonization with either
MBL-sufficient or MBL-deficient sera induced a two to three-
fold reduction in the subsequent phagocytosis of S. aureus. An
alternative role for MBL in S. aureus infection is suggested
independent of opsonization or complement activation. Bind-
ing of MBL to LTA via its carbohydrate recognition domain and
subsequent complexing with TLR2 to increase ligand delivery
is described to enhance TLR2 responses, as was measured by
cytokine release by murine macrophages. This TLR2-mediated
responses were only effective when S. aureus was delivered into
the phagosome (65).
In addition to MBL, other sugar pattern recognition molecules
as ficolins and collectins play a part in the lectin complement path-
way and aid in S. aureus recognition. They both contain lectin
activities within the C-terminus. Ficolins consists of collagen-
like long thin stretches and fibrinogen-like globular domains
with lectin activity, usually specific for N -acetylglucosamine (Glc-
NAc) (66). L-ficolin specifically binds to LTA, and immobilized
LTA from S. aureus binds L-ficolin complexes from sera. These
complexes are described to initiate lectin pathway-dependent C4
turnover (67). Collectins are a family of proteins that contain
both collagen-like regions and lectin domains and play a role in
opsonization and activation of neutrophils. In addition to MBL,
conglutinin and the surfactant proteins SP-A and SP-D, which
participate in the innate immunity of the lung, are other mem-
bers of this group. The collectins share structural similarities
with complement component C1q. SP-A may act directly as an
opsonin for micro-organisms by binding via their lectin domains
and enhance phagocytosis by alveolar macrophages. In addition,
SP-A directly binds to C1q and thereby facilitates uptake of C1q-
coated targets (68). SP-A and SP-D enhance bacterial (Escherichia
coli, S. pneumoniae, and S. aureus) uptake by human neutrophils
through a mechanism that involves both bacterial aggregation
and direct actions on neutrophils. Multimerization of SP-D is an
important parameter in its ability to increase uptake and differs
thereby from the classical opsonins IgG and complement (69).
Sp-A enhances the uptake of IgG-coated polystyrene beads by
inflammatory neutrophils via direct interaction with both the
opsonized beads and the neutrophils. In this case, the rat neu-
trophils were obtained from a lavage of LPS challenged lungs,
and here SP-A did not have a generalized activation effect on
neutrophils (70).
Finally, an important group of CRs on neutrophils are those for
the soluble anaphylatoxins C3a and C5a. The C3a receptor (C3aR)
and C5aR belong to the family of GPCRs. Neutrophils express
a large number of GPCRs that participate in the host defense.
They can sense bacterial peptides and toxins, e.g., formyl-peptide
receptors (FPR1 and FPR2), lipid mediators, e.g., leukotriene B4
receptor and platelet activating factor receptor, and chemokine
receptors (71, 72). Although known for their role in migration of
neutrophils, most of these ligands, including C3a and C5a, also
trigger direct cell activation, like ROS production, or “prime” cells
for subsequent activation by other agonists. A crucial role for C5a–
C5aR interaction was demonstrated for E. coli-induced phagocy-
tosis in lepirudin anticoagulated whole blood. Generation of the
anaphylatoxin C5a was essential and preceded the up-regulation of
CR3, which was required for the subsequent oxidative burst and
phagocytosis (73). Also for S. aureus in lepirudin treated whole
blood, complement was responsible for phagocytosis as well as
leukocyte activation (74).
NEUTROPHIL PRIMING
Neutrophil priming is a process that causes a dramatic increase
in the response of the cells and allows for faster and more effi-
cient response, including phagocytosis of invading pathogens (12,
75). Activating agents have direct effects on cell surface receptor
expression, but also intracellular in superoxide anion generation,
degranulation, and mediator release (70). In the primed state,
there is no increase in oxidase activity, yet subsequent stimulation
provokes a response that is larger than in non-primed, activated
cells. Neutrophil priming for enhanced oxidative burst, phago-
cytosis, and killing is initiated by several agents, such as soluble
complement activators C3a and C5a (74), interferon-γ (IFNγ)
(76, 77), interleukin-8 (il-8) (78), tumor necrosis factor-α (TNF-
α) (79), and granulocyte/macrophage colony-stimulating factor
(G-CSF & GM-CSF) (80). Stimulating receptors for G-CSF, GM-
CSF, and IFNγ also delay apoptosis thereby affecting survival of
neutrophils (81).
As mentioned, sensing of C5a is important in priming neu-
trophils by inducing up-regulation of CR3, which is crucial for
subsequent phagocytosis in whole blood. Regarding TNF-α, neu-
trophils express several members of the TNF receptor family with
diverse biological functions, including TNFR1 and TNFR2. TNF-α
is an important pro-inflammatory cytokine that both directly acti-
vates neutrophils and primes the cells for subsequent stimulation
including phagocytosis (82). Interleukin-1 plays also a major role
in the inflammatory response and S. aureus infections and trig-
gers a modest neutrophil activation (83, 84). They do express the
IL-1R1, a member of the IL-1/TLR super family with comparable
intracellular domains. The predominant receptor on neutrophils is
the decoy receptor IL-1RII lacking intracellular signaling domains.
Different classes of chemotactic agents, including C5a and il-8,
cause a rapid reduction in the IL-1 binding capacity by human
neutrophils (85).
Neutrophils express several innate immune receptors that are
involved in recognition of pathogens and danger signals and allow
priming of the cells. Those are found on the cell surface as well as in
intracellular endocytic compartments and lead to cell activation,
priming, and transcriptional changes. Neutrophils express most of
the known TLRs that recognize bacterial structures, most impor-
tantly TLR4, which recognizes lipopolysaccharide from Gram-
negative bacteria, and TLR2, which recognizes lipoproteins like
LTA from Gram-positive bacteria. Stimulation of neutrophils with
several TLR ligands stimulates phagocytosis of latex beads (86) and
enhance the oxidative burst (87). Neutrophils also express mem-
bers of the C-type lectins, such as Dectin-1, the receptor for fungal
β-glucans and the components of the NLRP3 inflammasome that
include the cytoplasmic NOD-like receptors sensing bacterial pro-
teoglycan degradation products and danger signals (88). TLRs are
not phagocytic receptors per se, but they are also internalized in
the process and therefore participate to the link between phagocy-
tosis and inflammatory responses by triggering the production of
cytokines.
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PHAGOCYTOSIS
Phagocytosis is defined as the engulfing of other cells, cell frag-
ments, and micro-organisms. Thereby it leads to sequestration
and elimination of e.g., dead cells after apoptosis, pathogens
like bacteria and uptake or delivery of substances by therapeu-
tic micro- or nanoparticles. Physical parameters, i.e., particle size,
shape, deformability, as well as biological parameters determine
the effectiveness of phagocytosis.
The actual phagocytosis process can be distinguished in several
phases: (1) attachment of the opsonized particle upon recognition
by specific receptors, (2) pseudopod extensions around attached
particle whereby it is still exposed to the environment (“zip-
pering”), and (3) completion of the engulfment resulting in the
formation of a phagosome, which is an outside-in compartment
inside the cell (Figure 2). The next steps involve mobilization and
fusion of the phagosome with different granule types resulting in
the liberation of granule content that is required for killing of the
microorganism (89, 90). Concurrently, a strong oxidative burst is
initiated in the phagosome by NADPH-dependent oxidases upon
triggering of specific cell surface receptors, leading to the genera-
tion of highly toxic ROS. Together with the granular content, ROS
play an important role in bacterial killing (91).
Neutrophils are capable of engulfing as many as 50 bacteria
whereby a substantial amount of surface area is internalized while
maintaining cell size and shape. For macrophages it is shown that
the surface membrane internalized during engulfment is replaced
from intracellular reservoirs. It is believed that during this replace-
ment of the plasma membrane originating from endoplasmatic
vesicles, focal exocytosis is effective leading to cytokine release. To
form an autonomous internal compartment, the phagosome must
undergo fission from the plasma membrane. The actual proteins
involved in this process remain not fully understood, but involve
dynamin and myosins. An important notion for any phagocytosis
process is that not all phagosomes are created equal (89).
Besides the appropriate opsonins and their ligands, neutrophil
versus monocytes/macrophages are of influence on this process,
also physical parameters have their influence, like target particle
size (>5µm) and even their shape as shown for S. pneumoniae.
Increasing the bacterial chain length, by natural changes in cellular
morphology or via antibody-mediated agglutination, promoted
complement-dependent killing (92). The density of both the lig-
and, e.g., IgG bound to the surface of the target particle, and the
receptor, e.g., FcγR, also influence phagocytosis. Using RAW 264.7
murine macrophage cell line, IgG density had different effects on
uptake depending on the particle size (93). Phagocytosis and IgG-
mediated triggering are sometimes misleading if immune com-
plexes are used to stimulate cells. Although these complexes could
be considered as very small particles, the nature of these complexes
differs from that of e.g., bacteria. Others call opsonized particles
immune complexes. By loading sheep red blood cells (ShRBC)
with increasing amounts of IgG, the increase in IgG density cor-
responds with increase in phagocytosis by mouse macrophages,
both in number of positive cells and ShRBC per cell (94). For high-
throughput assays, automatic imaging methods or flow cytometry
are becoming more popular and rely on fluorescent beads and cell
lines in microplate formats (95, 96).
Neutrophils are extremely efficient phagocytes and can inter-
nalize IgG-opsonized latex beads in <20 s (97). Localized gran-
ule secretion is important for phagocytosis and the generation
of an anti-microbial phagosome. Phagocytosis of IgG-opsonized
zymosan particles was very fast and most phagosomes were sealed
within 1–3 min (98). Fusion of azurophilic granules and specific
granules with the plasma membrane preceded phagosome seal-
ing, and the granule membrane markers (CD63 and CD66b) were
observed at the site of phagocytosis. Whereas, azurophilic gran-
ules are mainly secreted toward the forming/formed phagosome,
specific granules can fuse with the plasma membrane at any loca-
tion. A consumption of protons increases the pH, and early studies
even indicated alkaline levels in early phagosomes before the pH
gradually decreased (90, 99). It must be noted that during phago-
cytosis several signaling pathways are initiated that direct cellular
activities but are beyond the scope of this review (81, 100–103).
FIGURE 2 | Neutrophil phagocytosis of S. aureus. (A) Upon
recognition of opsonized S. aureus, neutrophils internalize the bacterium
in a phagosome where secretory granule content is released and ROS
are produced that mediate killing of the bacterium. (B) Confocal
microscopy image of S. aureus expressing green fluorescence protein
(green) attached (left) to and phagocytosed (right) by neutrophils [red,
membrane stain wheat germ agglutinin (WGA)-Alexa647, blue, nucleic
acid stain Syto82].
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KILLING PROCESS
The major task for neutrophils in the host defense is the elimi-
nation of pathogens by efficient uptake and subsequent killing.
Therefore, neutrophils are equipped with an arsenal of anti-
bacterial products stored in granules and an efficient massive
generation of ROS by the membrane-associated NADPH-oxidase
that can kill microorganism upon phagocytosis. In addition,
neutrophils can kill bacteria extracellularly by release of chro-
matin covered with granule contents and selected cytoplasmic
constituents providing NETs.
Neutrophils contain several granule subtypes that are subdi-
vided into peroxidase-positive granules [containing myeloper-
oxidase (MPO)], which are also called primary or azurophil
granules, and peroxidase-negative granules termed specific or sec-
ondary granules. However, granules are much more heterogeneous
with subsets defined by a selection of marker proteins (104).
MPO is one of the most abundant proteins in the neutrophil
azurophil granules and catalyzes the oxidation of halide ions in
the presence of hydrogen peroxide and generates hypochlorous
acid that aids in bacterial killing (105). The granules contain
a broad-spectrum of bactericidal and degradative proteins, but
also growth depriving factors. Lactoferrin binds iron and neu-
trophil gelatinase-associated lipocalin (NGAL) interferes with
siderophore-mediated iron acquisition thereby sequestering an
essential microbial growth factor (106). Lysozyme hydrolyzes β
(1–4) glycosidic linkages in the peptidoglycan layer, compromis-
ing bacterial integrity. Cationic anti-microbial peptides (CAPs)
such as defensins and cathelicidin-type peptides (LL37) bind with
high affinity into the bacterial membrane causing disruption (107–
109). Azurophil granules also contain a family of structurally
related serine proteases, cathepsin G, elastase, and proteinase 3,
with anti-microbial and regulatory activity (110, 111).
The neutrophil NADPH-oxidase is a multicomponent enzyme
complex that transfers electrons from NADPH onto molecu-
lar oxygen, thereby generating superoxide anion. Spontaneous
dismutation together with the granule-derived MPO and iron-
catalyzed reactions leads to the formation of several reactive ROS
that include hydrogen peroxide, hydroxyl radicals, hypochlor-
ous acid, and singlet oxygen. The transport of electrons is
mediated by the redox center that contains Cytochrome b558,
a flavo-hemeprotein composed of two subunits, gp91phox and
p22phox. Assembly of the NADPH-oxidase involves translocation
of three soluble components, p47phox, p67phox, p40phox, and a
GTP-binding protein onto the plasma membrane to form the
complete oxidase. This complex system is also carefully regulated
in place and time, and it is concurrently assembled with phago-
some formation (91). Specific KO mice are used to study the
contribution of the NADPH-oxidase complex in bacterial patho-
genesis and survival of the host. The oxidase response of these
KO neutrophils is severely reduced upon stimulation with parti-
cles (IgG latex beads or S. aureus), soluble mediators like fMLF,
or is adhesion dependent. Phagocytosis of bacteria by KO neu-
trophils is normal, but a clear defect is observed in killing of
S. aureus in vitro as well as in vivo (112). Both reactive oxy-
gen metabolites and neutrophil serine proteases contribute to
the host defense depending on the pathogen studied, as was
shown in the case of Aspergillus (111). The importance of an
intact oxidative burst in neutrophils is demonstrated by chronic
granulomatous disease (CGD; a primary immunodeficiency dis-
order of phagocytes) patients with a genetic defect in one of the
NADPH-oxidase subunits. These patients suffer from recurrent
bacterial infections, most commonly S. aureus, Aspergillus spp,
and Salmonella spp (113). The role of ROS in killing of bacte-
ria by neutrophils in vitro is evident when cells are treated with
diphenyleneiodonium (DPI), which binds strongly to flavopro-
teins and is thereby a powerful inhibitor of several important
enzymes including the NADPH-oxidase. Another defect is found
for MPO deficiency; patients are fairly asymptomatic and defects
are mainly found in the formation of NETs (9, 114). The oxidative
burst pumps electrons into the phagosome that is compensated by
a flux of K+ ions across the membrane in a pH dependent mat-
ter. This is an important trigger for the release of cationic granule
proteins (115, 116).
Oxidative deamination of L-arginine by nitric oxide (NO) syn-
thetase generates NO that together with superoxide anion forms
reactive nitrogen intermediates with anti-microbial activity. The
production of NO within phagocytes is an important component
of the innate immune response to infection, and requires inducible
NOS (iNOS). In mice macrophages are the source for NO, but in
human leukocytes levels of iNOS are far more regulated (105,
117, 118). The role of iNOS in human neutrophils is limited and
requires cytokine activation (119).
For effective bacterial killing, a critical concentration of neu-
trophils is required in suspension. Mathematical models have
been applied to examine this ratio, which was supported by
experimental data. By varying both neutrophil and bacterial con-
centrations (S. epidermidis), it was documented that the killing
rate requires a critical neutrophil concentration of 3–4× 105 per
ml, is independent of ratio neutrophils to bacteria, and fitted an
exponential function. The mathematical model fits the killing of
Gram-positive and Gram-negative bacteria, opsonized by IgG and
C3, by neutrophils in suspension (120). Further mathematical
modeling and in vitro experimental killing of serum-opsonized
S. aureus demonstrated that a critical neutrophil concentration
dictates the outcome. Here, the individual maximum bearable
bacterial concentration depended on neutrophil concentration,
phagocytic activity, and patient barrier integrity and varied by
orders of magnitude between patients (121).
Neutrophils can kill bacteria extracellular by release of NETs
that trap bacteria covered with anti-microbials. This release and
formation of NETs is the last step in an active neutrophil death
termed NETosis and requires the formation of ROS. Several dif-
ferent agonists trigger the NET formation, including cytokines,
microbial components, and bacteria itself. The extracellular traps
are described to be formed in vivo and to contribute to clear-
ing of infections (13, 122). In response to S. aureus, neutrophils
employ a very rapid (5–60 min) alternative process of NET for-
mation, independent of ROS, employing budding of vescicles.
This response requires live bacteria and was mimicked by Panton–
Valentine leukocidin as soluble mediator (123). Another member
of this pore-forming leukotoxins, LukGH (also known as LukAB),
also promotes the release of NETs (124). IgA-opsonized S. aureus
also rapidly initiates the formation of NETs probably due to the
robust production of ROS. In these circumstances killed bacteria
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or beads coated with IgA are also effective and engagement of the
FcαR is a prerequisite (125).
Killing of S. aureus by neutrophils is not only effective in sus-
pension but is also observed when bacteria are found in a biofilm.
In contrast to mouse macrophages, neutrophils are capable of
phagocytizing biofilm-associated S. aureus in vitro (126). Neu-
trophils migrate into the biofilm and enable clearance of bacteria
by phagocytosis, whereby the extent of cleareance is dependent on
the maturation state of the biofilm. Young developing biofilms are
more sensitive toward the attack by neutrophils compared to more
mature biofilms (127).
Opsonization with normal human serum did not change the
phagocytosis of bacteria in biofilms, while opsonization of dis-
persed S. aureus was enhanced. IgG coating of the biofilm induced
oxygen radical production that improved clearance of the biofilms
due to bacterial killing (128).
ANTI-OPSONIC/PHAGOCYTIC STRATEGIES
Phagocytosis by neutrophils is a very effective mechanism for
S. aureus clearance. However, staphylococci are not just mere
bystanders, and the bacteria can employ several anti-opsonic and
anti-phagocytic means to survive. Escape strategies can be found
for every step of phagocytosis, from binding and cleavage of
antibodies to escape from phagosomes.
The best way to prevent phagocytosis is to prevent the ini-
tial proper opsonization, either directly by taking a sugar coating
(capsule) that covers most of the more antigenic/immunogenic
surface-exposed proteins, or indirectly by employing decoy mole-
cules and active removal of opsonins. A rather thick polysaccharide
capsule is best known for the many pneumococcal serotypes, but
also for staphylococci a capsular polysaccharide efficiently hinders
phagocytosis by neutrophils. Up to 50% of clinical S. aureus iso-
lates have a capsule or microcapsule divided in up to 11 serotypes,
whereby most of them react with antibodies directed to cap-
sule type 5 or 8. These bacteria resist opsonophagocytosis and
hence killing when bacteria were grown under conditions for
optimal capsule production. These capsule polysaccharides and
their components are also used as candidates for vaccine devel-
opment against staphylococci. Specific antibodies directed against
the capsule provide efficient opsonization and thereby uptake by
neutrophils (129, 130). Recently an indirect covering of S. aureus
with a shield of fibrinogen is shown by the staphylococcal extra-
cellular fibrinogen-binding protein (Efb) that links the surface
C3b deposition with fibrinogen. Thereby Efb prevents binding of
phagocytic receptors to the opsonins C3b and IgG and subsequent
phagocytosis (131).
Another anti-opsonic strategy is the secretion of IgG-binding
proteins. The best known IgG-binding protein is staphylococ-
cal protein-A (SpA). This ubiquitously expressed protein is a
prominent cell wall-anchored protein, but it is also found in the
supernate. Typically, its C-terminal part is linked to the cell wall,
while the N-terminus contains five highly homologous extracellu-
lar Ig-binding domains in tandem. Each domain binds Igs through
the Fc and restricted Fab domain of the human heavy chain VH3
family. The residues involved in binding to Fab are distinct from
the residues that mediate binding to Fc part as the Fab fragments
through distinct residues (132). Fc-binding to SpA is thought to
protect staphylococci from opsonophagocytic killing (133–135).
However, the precise mechanism is still not clear. Binding of Ig is
essential though for S. aureus escape from host immune surveil-
lance in mice as a protein-A-deficient strain induces a less severe
arthritis and septic death, indicating that protein-A is a virulence
factor (136). S. aureus also contains another IgG-binding pro-
tein, S. aureus binder of IgG (Sbi) that exhibits two Ig-binding
domains similar to those of protein-A with comparable specificity
(137, 138). Sbi is a multifunctional bacterial protein, which also
acts a complement inhibitor and interferes with innate immune
recognition (139). In a whole blood assay, Sbi prevents neutrophil-
mediated opsonophagocytosis thereby promoting bacterial sur-
vival. The Sbi-KO bacteria show increased survival in whole blood
and better uptake by neutrophils (140). However, Sbi does not con-
tribute to S. aureus virulence in contrast to the Fcγ and VH3-type
Fab binding activities of SpA (141). The impact of “reverse” IgG-
binding on the interaction with host defense and invasive infection
is shown for streptococcal protein M1 and H. Antibodies bound via
Fab facilitate opsonization and killing by neutrophils whereas Fc-
binding to protein M and H protected against phagocytosis (142).
Another strategy to escape killing, is through cleavage of
IgG and C3, stretegies predominantly described for streptococci.
Staphylokinase (SAK) is a secreted protein that can form a com-
plex with human plasminogen resulting in the formation of active
plasmin, a broad-spectrum proteolytic enzyme. This facilitates
bacterial penetration into the surrounding tissues and is shown
to cleave bacterial surface-bound IgG and C3b molecules. Cleav-
age of these important opsonins results in diminished uptake of
the bacteria by neutrophils (143). Both staphylococcal proteins
Sbi and Efb bind simultaneously C3/C3b and plasminogen on the
surface of the bacterium and thereby enable the recruited plasmin
or SAK to cleave bound C3 and C3b as well as soluble C3a (144).
In addition to strategies targeting IgG for anti-phagocytic pur-
poses, staphylococci secrete many complement inhibitors to halt
effective phagocytosis. These include, amongst others, staphylo-
coccal complement inhibitor SCIN, extracellular complement-
binding protein Ecb, and staphylococcal superantigen-like protein
SSL7. They generally affect conversion of complement through
binding major complement convertase componants and halt the
complement cascade at several stages. As staphylococci have a
large arsenal of complement inhibitors, please refer to excellent
overviews (3, 145–147).
In addition to anti-opsonic strategies, bacteria, including S.
aureus, have developed strategies to evade killing after internaliza-
tion. Staphylococci can survive within the phagosome and have
developed several ways to escape neutrophil killing. Escape is
accomplished by employing toxins, like phenol-soluble modulins
and leukocidin AB, that lyse the neutrophil from within after
phagocytosis (148, 149). Toxin production in this bacterium is
mainly regulated by activation of the agr operon (150),and the sur-
vival of the bacterium inside the neutrophil could even contribute
to spread of the bacteria in the host (151). S. aureus also evades
the ROS mediated killing mechanism using scavengers like cata-
lase, superoxide dismutase (152, 153), and the golden carotenoid
pigment (154). With regard to NETs, some bacteria can escape
entrapment through secretion of endonucleases that can liberate
them from the traps. An alternative NET escape mechanism for S.
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aureus is by converting NETs to deoxyadenosine, which induces
macrophage cytotoxicity. Two secreted proteins, nuclease and
adenosine synthethase are required for this host cell death (155).
CONCLUDING REMARKS
For invading staphylococci, phagocytosis and killing by human
neutrophils is the biggest threat. Neutrophils are the only cells that
can effectively kill staphylococci by engulfment and subsequent
bombardment with proteases, amidases, anti-microbial peptides,
and proteins in concert with ROS that are generated during the
metabolic burst. Both complement and antibodies are crucial for
effective uptake and neutrophil activation. S. aureus is not an inno-
cent bystander in this process. It actively secretes several proteins
to impair every single step in this process from receptor modu-
lation, to complement inhibition to neutrophil lysis to protease,
anti-microbial peptide inhibition and resistance to ROS. For the
design of future novel anti-microbial strategies: therapeutic anti-
bodies, vaccines, and novel antibiotics, all this should be taken into
account. Still the best way to treat diseases is to help to enhance
the natural defense mechanisms that are already in place.
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